AU2001267708A1 - Novel process for preparing crystalline particles - Google Patents
Novel process for preparing crystalline particlesInfo
- Publication number
- AU2001267708A1 AU2001267708A1 AU2001267708A AU6770801A AU2001267708A1 AU 2001267708 A1 AU2001267708 A1 AU 2001267708A1 AU 2001267708 A AU2001267708 A AU 2001267708A AU 6770801 A AU6770801 A AU 6770801A AU 2001267708 A1 AU2001267708 A1 AU 2001267708A1
- Authority
- AU
- Australia
- Prior art keywords
- novel process
- crystalline particles
- preparing crystalline
- preparing
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/80—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
- B01F31/85—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations with a vibrating element inside the receptacle
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/45—Magnetic mixers; Mixers with magnetically driven stirrers
- B01F33/452—Magnetic mixers; Mixers with magnetically driven stirrers using independent floating stirring elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/80—Mixing plants; Combinations of mixers
- B01F33/82—Combinations of dissimilar mixers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0016002 | 2000-06-29 | ||
| GBGB0016002.8A GB0016002D0 (en) | 2000-06-29 | 2000-06-29 | Novel process for preparing crystalline particles |
| PCT/GB2001/002936 WO2002000200A1 (en) | 2000-06-29 | 2001-06-29 | Novel process for preparing crystalline particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001267708A1 true AU2001267708A1 (en) | 2002-01-08 |
Family
ID=9894695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001267708A Abandoned AU2001267708A1 (en) | 2000-06-29 | 2001-06-29 | Novel process for preparing crystalline particles |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040091407A1 (en) |
| EP (1) | EP1294362A1 (en) |
| JP (1) | JP2004500985A (en) |
| AU (1) | AU2001267708A1 (en) |
| GB (1) | GB0016002D0 (en) |
| WO (1) | WO2002000200A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6869551B2 (en) | 2001-03-30 | 2005-03-22 | Picoliter Inc. | Precipitation of solid particles from droplets formed using focused acoustic energy |
| US6596206B2 (en) | 2001-03-30 | 2003-07-22 | Picoliter Inc. | Generation of pharmaceutical agent particles using focused acoustic energy |
| EP1423096B1 (en) * | 2001-08-29 | 2006-08-16 | Dow Global Technologies Inc. | A process for preparing crystalline drug particles by means of precipitation |
| GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
| US20040197275A1 (en) | 2002-10-17 | 2004-10-07 | Ecole Polytechnique Federale De Lausanne | Process for the manufacture of powders of inhalable medicaments |
| WO2004034943A2 (en) * | 2002-10-17 | 2004-04-29 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Process and reactor for the manufacture of powders of inhalable medicaments |
| ES2437565T3 (en) * | 2003-06-30 | 2014-01-13 | Alza Corporation | Formulations for coated microprojections containing non-volatile counterions |
| PE20060272A1 (en) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST |
| GB0504314D0 (en) * | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
| EP1871344A4 (en) * | 2005-03-18 | 2012-05-02 | Nanomaterials Tech Pte Ltd | Inhalable drug |
| AU2006225066B2 (en) * | 2005-03-18 | 2010-07-29 | Nmt Pharmaceuticals Pte Ltd | Inhalable drug |
| GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| FR2897267A1 (en) * | 2006-02-16 | 2007-08-17 | Flamel Technologies Sa | MULTIMICROPARTICULAR PHARMACEUTICAL FORMS FOR PER OS ADMINISTRATION |
| GB0705159D0 (en) | 2007-03-19 | 2007-04-25 | Prosonix Ltd | Process for making crystals |
| GB0711680D0 (en) * | 2007-06-18 | 2007-07-25 | Prosonix Ltd | Process |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7501406A (en) * | 1975-02-06 | 1976-08-10 | Dso Pharmachim | Crystallisation of tetracycline hydrochloride - accelerated by subjecting to high-frequency vibrations, with purer, less toxic prod. formed |
| GB9313642D0 (en) * | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| GB9413202D0 (en) * | 1994-06-30 | 1994-08-24 | Univ Bradford | Method and apparatus for the formation of particles |
| SE9501384D0 (en) * | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
| SE9804000D0 (en) * | 1998-11-23 | 1998-11-23 | Astra Ab | New composition of matter |
| GB9828721D0 (en) * | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
| DK1173265T3 (en) * | 1999-01-29 | 2006-04-10 | Bristol Myers Squibb Co | Apparatus and method for crystallization with ultrasound rays |
| US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
-
2000
- 2000-06-29 GB GBGB0016002.8A patent/GB0016002D0/en not_active Ceased
-
2001
- 2001-06-29 EP EP01945493A patent/EP1294362A1/en not_active Withdrawn
- 2001-06-29 AU AU2001267708A patent/AU2001267708A1/en not_active Abandoned
- 2001-06-29 US US10/312,433 patent/US20040091407A1/en not_active Abandoned
- 2001-06-29 JP JP2002504982A patent/JP2004500985A/en active Pending
- 2001-06-29 WO PCT/GB2001/002936 patent/WO2002000200A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002000200A1 (en) | 2002-01-03 |
| US20040091407A1 (en) | 2004-05-13 |
| GB0016002D0 (en) | 2000-08-23 |
| JP2004500985A (en) | 2004-01-15 |
| EP1294362A1 (en) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001256732A1 (en) | Process for producing crystal | |
| AU2001241727A1 (en) | Process for producing para-xylene | |
| AU2002230470A1 (en) | Process for preparing pouches | |
| AU3994299A (en) | Process for preparing 4-aminodiphenylamines | |
| AU2001267708A1 (en) | Novel process for preparing crystalline particles | |
| AU2464401A (en) | Process for the preparation of oligomeric compounds | |
| AU5884700A (en) | Process for making amine compounds | |
| AU4363401A (en) | Novel process for preparing (+)-cis-sertraline | |
| AU2001263046A1 (en) | Process for preparing chitosan particles | |
| AU2001227086A1 (en) | Process for preparing 2-hydroxy-4-methylthiobutanoic acid | |
| AU2001273762A1 (en) | Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols | |
| AU2001291313A1 (en) | Process for making 3-amino-2-chloro-4-methylpyridine | |
| AU2001262226A1 (en) | Process for the preparation of sterically hindered aryloxyamines | |
| AU2229201A (en) | Process for producing glycine | |
| AU1149401A (en) | Process for preparing jam | |
| AU2001248825A1 (en) | Process for producing microsphere | |
| AU2001289303A1 (en) | Process for producing crystalline tagatose | |
| AU2001232158A1 (en) | Crystallizing process | |
| AU6163000A (en) | Process for producing polypropylene | |
| AU3818900A (en) | Process for the preparation of substituted piperidines | |
| AU2002222604A1 (en) | Process for preparing substance GM-95 | |
| AU2001280244A1 (en) | Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine | |
| AU2001264385A1 (en) | Novel cephalosporin compounds and process for preparing the same | |
| AU2001245429A1 (en) | Process for preparing pure crystalline lorazepam | |
| AU2001226654A1 (en) | Process for preparing esters |